AWS GraphRAG significantly accelerates pharmaceutical research by integrating previously separated proprietary databases into a unified and queryable knowledge graph. Historically, initial data gathering and screening phases took over six months per iteration, yielding a low five percent success rate.
This integration process reduces the time it takes to gather and analyze data, allowing researchers to move faster and make more informed decisions in drug development. With this new setup, teams can now quickly query the combined database and gain insights that were previously impossible to obtain.
The results of this deployment are impressive - reducing drug research cycles by 87 percent. This is achieved through a significant increase in efficiency, as well as improved accuracy and effectiveness. By unifying the data into one source, researchers can better identify potential leads and develop new treatments more quickly.